COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021
- PMID: 37584882
- PMCID: PMC10504101
- DOI: 10.1007/s10549-023-06962-8
COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021
Abstract
Purpose: Evaluate the COVID-19 pandemic impact on breast cancer detection method, stage and treatment before, during and after health care restrictions.
Methods: In a retrospective tertiary cancer care center cohort, first primary breast cancer (BC) patients, years 2019-2021, were reviewed (n = 1787). Chi-square statistical comparisons of detection method (patient (PtD)/mammography (MamD), Stage (0-IV) and treatment by pre-pandemic time 1: 2019 + Q1 2020; peak-pandemic time 2: Q2-Q4 2020; pandemic time 3: Q1-Q4 2021 (Q = quarter) periods and logistic regression for odds ratios were used.
Results: BC case volume decreased 22% in 2020 (N = 533) (p = .001). MamD declined from 64% pre-pandemic to 58% peak-pandemic, and increased to 71% in 2021 (p < .001). PtD increased from 30 to 36% peak-pandemic and declined to 25% in 2021 (p < .001). Diagnosis of Stage 0/I BC declined peak-pandemic when screening mammography was curtailed due to lock-down mandates but rebounded above pre-pandemic levels in 2021. In adjusted regression, peak-pandemic stage 0/I BC diagnosis decreased 24% (OR = 0.76, 95% CI: 0.60, 0.96, p = .021) and increased 34% in 2021 (OR = 1.34, 95% CI: 1.06, 1.70, p = .014). Peak-pandemic neoadjuvant therapy increased from 33 to 38% (p < .001), primarily for surgical delay cases.
Conclusions: The COVID-19 pandemic restricted health-care access, reduced mammography screening and created surgical delays. During the peak-pandemic time, due to restricted or no access to mammography screening, we observed a decrease in stage 0/I BC by number and proportion. Continued low case numbers represent a need to re-establish screening behavior and staffing.
Keywords: Breast cancer; COVID-19; Diagnosis; Mammography; Stage; Treatment.
© 2023. The Author(s).
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures
References
-
- Governor of Washington (2022) Proclamation by the Governor amending proclamation 20 – 05. Public Meetings Act and Public Records Act. https://www.governor.wa.gov/sites/default/files/proclamations/20-28.2%20...
-
- Emergency Proclamation by the governor amending proclamations 20-05, and 20-24. et seq. 20-24.3 Restrictions on Non-Urgent Medical Procedures. https://wa.gov/. Accessed June 15 2022
-
- The American Society of Breast Surgeons and The American College of Radiology (2021) Joint statement on breast screening exams during the Covid-19 pandemic. ASBrS and ACR Joint Statement on Breast Screening Exams During the COVID-19 Pandemic (breastsurgeons.org). Accessed December 2021
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
